Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe displayed site revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study-record content and indicating that access to the record is blocked.SummaryDifference18%

- Check62 days agoChange DetectedMelanoma was added to the related topics list and a related topic 'MedlinePlus Genetics' was added. These changes expand the page's topical metadata to improve discoverability and linkage to disease and genetics resources without modifying study details.SummaryDifference0.2%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.